Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: Implications for Sjogren-Larsson syndrome

William B. Rizzo, Eric Heinz, Marcia Simon, Debra A. Craft

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

The enzyme that catalyzes the oxidation of fatty aldehyde derived from ether glycerolipid catabolism has not been identified. To determine whether microsomal fatty aldehyde dehydrogenase (FALDH) is responsible, we investigated the metabolism of 1-O-[9,10-3 H-octadecyl]-glycerol ([3H]OG) in FALDH-deficient cultured cells from patients with Sjogren-Larsson syndrome (SLS) and in mutant Chinese hamster ovary (CHO) cells. Intact fibroblasts from SLS patients incubated with [3H]OG showed a selective deficiency (38±7% of normal) in the incorporation of radioactivity into fatty acid, but no decrease in incorporation of radioactivity into fatty alcohol, total lipids and phosphatidylethanolamine (PE). Consistent with fatty aldehyde accumulation, incorporation of radioactivity into N-alkyl-phosphatidylethanolamine, which is derived from Schiff base formation of free aldehyde with PE, was 4-fold higher in SLS fibroblasts compared to normal controls. Similar results were seen with SLS keratinocytes, whereas FALDH-deficient CHO cells showed a more profound reduction in radioactive fatty acid to 12±2% of normal. These results implicate FALDH in the oxidation of ether-derived fatty aldehyde in human and rodent cells. Metabolism of ether glycerolipids is a previously unrecognized source of fatty aldehyde that may contribute to the pathogenesis of SLS. (C) 2000 Elsevier Science B.V.

Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1535
Issue number1
DOIs
StatePublished - Dec 15 2000

Fingerprint

long-chain-aldehyde dehydrogenase
Sjogren-Larsson Syndrome
Aldehydes
Ether
Radioactivity
Cricetulus
Ovary
Fatty Acids
Fibroblasts
Fatty Alcohols
Schiff Bases
Keratinocytes
Glycerol
Cultured Cells
Rodentia
Lipids

Keywords

  • Aldehyde dehydrogenase
  • Ether lipid
  • Fatty aldehyde
  • Metabolism
  • Plasmalogen

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology

Cite this

@article{d6dc49d283e2453a81c4d54a18b65099,
title = "Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: Implications for Sjogren-Larsson syndrome",
abstract = "The enzyme that catalyzes the oxidation of fatty aldehyde derived from ether glycerolipid catabolism has not been identified. To determine whether microsomal fatty aldehyde dehydrogenase (FALDH) is responsible, we investigated the metabolism of 1-O-[9,10-3 H-octadecyl]-glycerol ([3H]OG) in FALDH-deficient cultured cells from patients with Sjogren-Larsson syndrome (SLS) and in mutant Chinese hamster ovary (CHO) cells. Intact fibroblasts from SLS patients incubated with [3H]OG showed a selective deficiency (38±7{\%} of normal) in the incorporation of radioactivity into fatty acid, but no decrease in incorporation of radioactivity into fatty alcohol, total lipids and phosphatidylethanolamine (PE). Consistent with fatty aldehyde accumulation, incorporation of radioactivity into N-alkyl-phosphatidylethanolamine, which is derived from Schiff base formation of free aldehyde with PE, was 4-fold higher in SLS fibroblasts compared to normal controls. Similar results were seen with SLS keratinocytes, whereas FALDH-deficient CHO cells showed a more profound reduction in radioactive fatty acid to 12±2{\%} of normal. These results implicate FALDH in the oxidation of ether-derived fatty aldehyde in human and rodent cells. Metabolism of ether glycerolipids is a previously unrecognized source of fatty aldehyde that may contribute to the pathogenesis of SLS. (C) 2000 Elsevier Science B.V.",
keywords = "Aldehyde dehydrogenase, Ether lipid, Fatty aldehyde, Metabolism, Plasmalogen",
author = "Rizzo, {William B.} and Eric Heinz and Marcia Simon and Craft, {Debra A.}",
year = "2000",
month = "12",
day = "15",
doi = "10.1016/S0925-4439(00)00077-6",
language = "English (US)",
volume = "1535",
pages = "1--9",
journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",
issn = "0925-4439",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism

T2 - Implications for Sjogren-Larsson syndrome

AU - Rizzo, William B.

AU - Heinz, Eric

AU - Simon, Marcia

AU - Craft, Debra A.

PY - 2000/12/15

Y1 - 2000/12/15

N2 - The enzyme that catalyzes the oxidation of fatty aldehyde derived from ether glycerolipid catabolism has not been identified. To determine whether microsomal fatty aldehyde dehydrogenase (FALDH) is responsible, we investigated the metabolism of 1-O-[9,10-3 H-octadecyl]-glycerol ([3H]OG) in FALDH-deficient cultured cells from patients with Sjogren-Larsson syndrome (SLS) and in mutant Chinese hamster ovary (CHO) cells. Intact fibroblasts from SLS patients incubated with [3H]OG showed a selective deficiency (38±7% of normal) in the incorporation of radioactivity into fatty acid, but no decrease in incorporation of radioactivity into fatty alcohol, total lipids and phosphatidylethanolamine (PE). Consistent with fatty aldehyde accumulation, incorporation of radioactivity into N-alkyl-phosphatidylethanolamine, which is derived from Schiff base formation of free aldehyde with PE, was 4-fold higher in SLS fibroblasts compared to normal controls. Similar results were seen with SLS keratinocytes, whereas FALDH-deficient CHO cells showed a more profound reduction in radioactive fatty acid to 12±2% of normal. These results implicate FALDH in the oxidation of ether-derived fatty aldehyde in human and rodent cells. Metabolism of ether glycerolipids is a previously unrecognized source of fatty aldehyde that may contribute to the pathogenesis of SLS. (C) 2000 Elsevier Science B.V.

AB - The enzyme that catalyzes the oxidation of fatty aldehyde derived from ether glycerolipid catabolism has not been identified. To determine whether microsomal fatty aldehyde dehydrogenase (FALDH) is responsible, we investigated the metabolism of 1-O-[9,10-3 H-octadecyl]-glycerol ([3H]OG) in FALDH-deficient cultured cells from patients with Sjogren-Larsson syndrome (SLS) and in mutant Chinese hamster ovary (CHO) cells. Intact fibroblasts from SLS patients incubated with [3H]OG showed a selective deficiency (38±7% of normal) in the incorporation of radioactivity into fatty acid, but no decrease in incorporation of radioactivity into fatty alcohol, total lipids and phosphatidylethanolamine (PE). Consistent with fatty aldehyde accumulation, incorporation of radioactivity into N-alkyl-phosphatidylethanolamine, which is derived from Schiff base formation of free aldehyde with PE, was 4-fold higher in SLS fibroblasts compared to normal controls. Similar results were seen with SLS keratinocytes, whereas FALDH-deficient CHO cells showed a more profound reduction in radioactive fatty acid to 12±2% of normal. These results implicate FALDH in the oxidation of ether-derived fatty aldehyde in human and rodent cells. Metabolism of ether glycerolipids is a previously unrecognized source of fatty aldehyde that may contribute to the pathogenesis of SLS. (C) 2000 Elsevier Science B.V.

KW - Aldehyde dehydrogenase

KW - Ether lipid

KW - Fatty aldehyde

KW - Metabolism

KW - Plasmalogen

UR - http://www.scopus.com/inward/record.url?scp=0034672630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034672630&partnerID=8YFLogxK

U2 - 10.1016/S0925-4439(00)00077-6

DO - 10.1016/S0925-4439(00)00077-6

M3 - Article

C2 - 11113626

AN - SCOPUS:0034672630

VL - 1535

SP - 1

EP - 9

JO - Biochimica et Biophysica Acta - Molecular Basis of Disease

JF - Biochimica et Biophysica Acta - Molecular Basis of Disease

SN - 0925-4439

IS - 1

ER -